INS and Hyperglycemia: These changes were accompanied by a reduced propotion of islets with insulitis>75% (Figure 5H and 5E), an increase in MafA and an enhancement in insulin expression confirming that B. breve was a key bacterial component of the gut microbiota that was needed to protect against the development of hyperglycemia (Figure 5I-J).